Home About
Fitness Precision Medicine Recovery Mental Performance MedLab MedSpa
Explore All Blog Getting Started Join Waitlist
ALYZE Hormone Replacement Therapy
Precision Medicine

Hormone Replacement Therapy

Hormones orchestrate every system in your body. When levels decline with age, the effects cascade — from energy and cognition to cardiovascular health and body composition. ALYZE restores optimal hormone balance through precision-dosed, biomarker-guided protocols.

Benefits Usage Guide Research
Health Benefits

Why HRT?

Hormone optimization is one of the most well-studied interventions in precision medicine. Here's what the clinical evidence demonstrates.

Cardiovascular Protection

The landmark TRAVERSE trial (5,246 men) confirmed that testosterone replacement therapy is noninferior to placebo for major adverse cardiac events. When initiated at the right time, HRT reduces cardiovascular risk and all-cause mortality.

5,246

Bone Density

Intramuscular testosterone is associated with an 8% gain in lumbar bone mineral density. In hypogonadal men, testosterone therapy increases spinal BMD by 5% and trabecular BMD by 14%, reducing fracture risk significantly.

+8%

Lean Muscle Mass

Testosterone therapy decreases subcutaneous fat and increases lean body mass in men with acquired hypogonadism. Combined with resistance training, optimized hormones accelerate muscle protein synthesis and recovery.

Energy & Vitality

Low testosterone is associated with fatigue, reduced motivation, and diminished quality of life. Clinical trials consistently show TRT improves energy levels, mood, and overall vitality in symptomatic hypogonadal patients.

Cognitive Function

Hormone optimization supports neuroprotective pathways. When initiated within the appropriate therapeutic window, HRT has been associated with reduced risk of cognitive decline and improved mental clarity and focus.

Sexual Health

The TestES evidence synthesis of 35 trials (5,601 participants) confirmed that TRT improved sexual function across nearly all patient subgroups. Libido, erectile function, and overall sexual satisfaction all demonstrate significant improvement.

5,601
Usage Guide

How we approach HRT.

01

Comprehensive Hormone Panel

Your journey begins with an extensive blood panel through the ALYZE MedLab — testosterone (total and free), estradiol, DHEA-S, thyroid markers, cortisol, SHBG, and more. We measure what matters before prescribing anything.

02

Practitioner Consultation

Your ALYZE physician reviews your labs, symptoms, health history, and goals. Together, you build a personALYZEd plan — the right hormone, the right dose, the right delivery method for your biology.

03

Protocol Initiation

Depending on your needs, HRT may involve topical gels, injections, or pellets. Your practitioner will walk you through proper administration and set expectations for onset of effects — typically 3–6 weeks for initial changes.

04

Ongoing Monitoring

Hormones are not set-and-forget. Your ALYZE protocol includes regular follow-up labs at 6–8 week intervals to fine-tune dosing, monitor safety markers (hematocrit, PSA, lipids), and optimize your response.

05

Long-Term Optimization

As your body responds, your protocol evolves. We adjust based on biomarkers, symptom resolution, and your changing goals. The objective is sustained optimization — not just correction.

Pro Tips

  • Timing matters — research shows benefits are greatest when HRT is initiated early in hormone decline
  • Combine with resistance training for synergistic effects on body composition and bone density
  • Sleep optimization amplifies HRT benefits — growth hormone peaks during deep sleep
  • Monitor labs consistently — even when you feel great, biomarkers tell the full story
  • Nutrition plays a role — adequate protein and micronutrients support hormone metabolism
  • Be patient — full effects of HRT typically manifest over 3–6 months
  • Your ALYZE protocol integrates HRT with your fitness, recovery, and nutrition plans for compounding results

Important: Hormone replacement therapy requires medical supervision and is only prescribed after comprehensive lab evaluation and clinical assessment. HRT is contraindicated in individuals with certain cancers, polycythemia, severe sleep apnea, or uncontrolled heart failure. Women who are pregnant or breastfeeding should not use HRT. All protocols require ongoing monitoring of safety biomarkers. Report any unusual symptoms to your ALYZE practitioner immediately.

Clinical Research

The evidence.

Hormone replacement therapy is supported by decades of clinical research including large-scale randomized controlled trials. These are the landmark studies.

Cardiovascular Safety · RCT

Cardiovascular Safety of Testosterone-Replacement Therapy (TRAVERSE Trial)

Lincoff et al. · New England Journal of Medicine · 2023 · n = 5,246 (RCT)
In men with hypogonadism and high cardiovascular risk, testosterone-replacement therapy was noninferior to placebo for major adverse cardiac events (HR 0.96; 95% CI 0.78–1.17; P<0.001 for noninferiority).
View on PubMed →
Evidence Synthesis · Meta-Analysis

The Effects and Safety of Testosterone Replacement Therapy for Men with Hypogonadism: the TestES Evidence Synthesis

Milne et al. · Health Technology Assessment · 2024 · 35 trials, n = 5,601
TRT improved quality of life and sexual function across nearly all patient subgroups. No significant difference in cardiovascular events between TRT (7.5%) and placebo (7.2%) groups.
View on PubMed →
Mortality · Cardiovascular

Menopausal Hormone Replacement Therapy and Reduction of All-Cause Mortality and Cardiovascular Disease

Hodis & Mack · Cancer Journal · 2022
When initiated within 10 years of menopause, HRT reduces all-cause mortality and risks of coronary disease, osteoporosis, and dementias — establishing HRT as a time-dependent primary CVD prevention therapy.
View on PubMed →
Bone Health · Meta-Analysis

Testosterone Use in Men and Its Effects on Bone Health: A Systematic Review and Meta-Analysis

Tracz et al. · Journal of Clinical Endocrinology & Metabolism · 2006
Intramuscular testosterone was associated with an 8% gain in lumbar bone mineral density (95% CI, 4%–13%). Transdermal testosterone showed no significant effect on BMD.
View on PubMed →
Body Composition · Bone

Increase in Bone Density and Lean Body Mass During Testosterone Administration in Men with Acquired Hypogonadism

Katznelson et al. · Journal of Clinical Endocrinology & Metabolism · 1996
Spinal BMD increased by 5% and trabecular BMD by 14% (P<0.001). Testosterone therapy decreased subcutaneous fat and increased lean muscle mass in hypogonadal men.
View on PubMed →
Cardiovascular · Meta-Analysis

Association Between Testosterone Replacement Therapy and Cardiovascular Outcomes: A Meta-Analysis of 30 Randomized Controlled Trials

Sood et al. · Current Problems in Cardiology · 2024 · 30 RCTs, n = 11,502
Across 30 trials with 11,502 patients, incidence of CVD events, stroke, myocardial infarction, all-cause mortality, and CVD mortality were not significantly different between TRT and control groups.
View on PubMed →

Latest research.

Recent peer-reviewed studies on hormone replacement therapy, automatically sourced from PubMed.

Auto-updated from PubMed

Loading latest research...
ALYZE facility
ALYZE facility
ALYZE facility
ALYZE facility

Optimize your

hormones.
longevity.
vitality.
health.
hormones.
Join the Waitlist

Bountiful, Utah · alyze.health

The information provided on this page is for general informational and educational purposes only and is not intended as medical advice. The research cited is from peer-reviewed journals and is presented for educational purposes. Individual results may vary. Always consult with a qualified healthcare provider before beginning any new wellness practice, including hormone replacement therapy.